Crossmark

Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1016/j.medcle.2024.05.008

Published Print: 2024-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Martinez-Molina, Cristina https://orcid.org/0000-0001-5079-613X
Guardiola Tey, Jose Maria https://orcid.org/0000-0001-5537-2600
Ruiz-Ramos, Jesus https://orcid.org/0000-0002-0008-641X
Feliu, Anna https://orcid.org/0000-0003-2074-2231
Puig-Campmany, Mireia https://orcid.org/0000-0001-6416-3341
Vidal, Silvia https://orcid.org/0000-0002-3909-6682
Corominas, Hèctor https://orcid.org/0000-0002-7738-6787
License Information

Text and Data Mining valid from 2024-10-01

Text and Data Mining valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01
More Information

This article is maintained by: Elsevier

Article Title: Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2024.05.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2024.05.007

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.